You are using an older browser version. Please use a supported version for the best MSN experience.

Breakthrough technique could combat cancer drug resistance

Relaxnews (AFP) logoRelaxnews (AFP) 2/9/2018

The technique uses nanoparticles and near infrared laser treatment to "turn off" cancer cells' multidrug resistance capabilities for several days. © Provided by AFPRelaxNews The technique uses nanoparticles and near infrared laser treatment to "turn off" cancer cells' multidrug resistance capabilities for several days. Researchers in the USA have developed a new technique to combat the resistance of cancer cells to chemotherapy drugs. The findings are published in the journal Nature Communications.

The ability of cancer cells to develop resistance to chemotherapy drugs -- known as multidrug resistance -- remains a major cause of tumor recurrence and cancer metastasis.

Researchers in the USA have made a major breakthrough in the fight against multiresistant cells with a technique using nanoparticles to administer drugs to cancer cells. The technique involves using specially designed nanoparticles alongside near infrared laser treatment to make cancer cells lose their multidrug resistance for several days.

This creates a therapeutic window during which chemotherapy can be administered, potentially in lower doses, inhibiting the growth of multidrug-resistant tumors after surgery or earlier treatment with reduced drug toxicity to healthy organs.

The technique essentially reduces the amount of energy available to efflux pumps within cancer cells. These efflux pumps protect the cells by expelling unwanted toxic substances (antibiotics, heavy metals, drugs). As well as removing toxins from the cells, the efflux pumps also remove almost all clinically relevant chemotherapy drugs, the scientists explain.

"For years, researchers have focused on delivering more chemotherapy drugs into cancer cells using nanoparticles, without targeting the root of drug resistance," explains University of Maryland Fischell Department of Bioengineering Professor Xiaoming "Shawn."

"This meant that the cancer cells maintained their ability to expel the chemotherapy drugs, which limited any enhancement of the cancer therapy. To address this challenge, our research group is using nanoparticles not only to deliver more chemotherapy drugs to the target site within cancer cells, but also to compromise the function of the efflux pumps and thereby significantly improve safety and efficacy of cancer therapy," concludes the specialist.

The research team, whose findings are published in the journal Nature Communications, also included scientists from Ohio State University, University of Virginia, University of Missouri School of Medicine, Shanghai University of Traditional Chinese Medicine, and Indiana University School of Medicine.

The study is available here:

Gallery: 13 signs of cancer men are likely to ignore (courtesy Reader's Digest) Difficulty urinating: <p>If it’s consistently difficult to urinate, or there’s blood in your urine or semen, or if you experience unexplained erectile dysfunction, see your doctor; these could be <a href=''>symptoms of prostate cancer</a>. 'Unfortunately, there aren’t noticeable symptoms of prostate cancer until the aggressive stages,' says Moshe Shike, MD, gastroenterologist at Memorial Sloan Kettering Cancer Center in New York City. Dr. Shike says he frequently sees patients who ignore these symptoms for up to six months before they seek help, but the sooner you check out your symptoms, the better.</p>If you have the opposite problem, and <a href=''>you have to pee all the time, here's what that might mean</a>.Reader’s Digest is working with Stand Up to Cancer, an initiative that funds groundbreaking research projects to help bring new treatments to patients faster. Here’s how you can <a href='[timestamp]'>join the movement to help END CANCER in our lifetimes</a>. 13 Signs of Cancer Men Are Likely to Ignore

image beaconimage beaconimage beacon